APA (7th ed.) Citation

FR, M., AM, F., A, V., C, V., M, B., C, O., . . . M, M. (2024). Severe infections in patients with chronic lymphocytic leukemia included in trials investigating BTK and BCL2 inhibitors. Critical reviews in oncology/hematology, 201, 104408. https://doi.org/10.1016/j.critrevonc.2024.104408

Chicago Style (17th ed.) Citation

FR, Mauro, Frustaci AM, Visentin A, Vitale C, Bartoletti M, Oltolini C, Zappulo E, and Mikulska M. "Severe Infections in Patients with Chronic Lymphocytic Leukemia Included in Trials Investigating BTK and BCL2 Inhibitors." Critical Reviews in Oncology/hematology 201 (2024): 104408. https://doi.org/10.1016/j.critrevonc.2024.104408.

MLA (9th ed.) Citation

FR, Mauro, et al. "Severe Infections in Patients with Chronic Lymphocytic Leukemia Included in Trials Investigating BTK and BCL2 Inhibitors." Critical Reviews in Oncology/hematology, vol. 201, 2024, p. 104408, https://doi.org/10.1016/j.critrevonc.2024.104408.